Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiotherapy with Selective Bladder Preservation for Muscle-Invading Bladder Cancer
NCT00003930Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Sep 1999
- Primary completion
- Jul 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of paclitaxel, cisplatin, gemcitabine in bladder cancer, sponsored by NRG Oncology. Started Sep 1999; status: completed.
02
Drugs
paclitaxelcisplatingemcitabine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00003930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003930.